戻る
Oryzon Genomics SA (ORYZF)価格
ORYZF 株価推移チャート
ORYZF 収入
Oryzon Genomics SA
$3.36
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$3.36
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$3.36
始値
$3.03
当日レンジ
$3.03 - $3.36
52週レンジ
$1.56 - $4.37
取引高
5.0K
平均取引高
2
1株当たり利益(TTM)
-0.04
配当利回り
--
時価総額
$264.9M
ORYZFとは何ですか？
Oryzon Genomics SA is a clinical stage biopharmaceutical company, which engages in the discovery, research, and development of new chemical entities, as well as conducting clinical trials. The company is headquartered in Cornella De Llobregat, Barcelona and currently employs 44 full-time employees. The company went IPO on 2015-12-10. Its compounds in clinical development include iadademstat (ORY-lOOl), an LSD1 inhibitor that is in Phase II trials for the treatment of acute myeloid leukemia and small cell lung cancer; and vafidemstat (ORY-2001), an LSD1 inhibitor optimized for the Central Nervous System (CNS), in multiple Phase II clinical trials for the treatment of CNS and psychiatric illnesses. The firm also has ORY-3001, in preclinical development for the treatment of non-oncological diseases and has additional programs to develop inhibitors against other epigenetic targets.